Gastric cancers, with gastric adenocarcinoma (GAC) as the most common histological type,
impose a considerable global health burden. Although the screening strategies for early …

Context: ERBB2 (erb-b2 receptor tyrosine kinase 2 or HER2) is currently the only biomarker
established for selection of a specific therapy for patients with advanced gastroesophageal …

胃癌是我国常见的恶性肿瘤之一, 严重威胁我国居民生命健康. 胃癌高风险人群接受筛查和早诊
早治能够有效降低胃癌的发病率和死亡率. 制定符合中国国情的胃癌筛查与早诊早治指南 …

Background The additive or synergistic sustained antitumour effect of immune checkpoint
inhibitors in combination with oxaliplatin-based chemotherapy has previously been …

Background Liver metastasis (LM) is a major obstacle to the prognosis of gastric cancer
(GC) patients, but the molecular mechanism underlying gastric cancer liver metastasis (GC …

Background. In the face of poor prognosis and immunotherapy failure of gastric cancer (GC),
this project tried to find new potential biomarkers for predicting prognosis and precision …

Background Patients with early gastric cancers that are limited to gastric mucosa or
submucosa usually have an advanced loss of mucosal glandular tissue (glandular atrophy) …

Background Patients with advanced gastric or gastro-oesophageal junction cancer
refractory to, or intolerant of, two or more previous regimens of chemotherapy have a poor …

China is one of the countries with the highest incidence of gastric cancer. There are
differences in epidemiological characteristics, clinicopathological features, tumor biological …

Background Nivolumab is approved as an option for third-or later-line treatment of advanced
gastric/gastroesophageal junction (G/GEJ) cancer in several countries after ATTRACTION-2 …